MDM2 and breast cancer: Alternatively, the observation that high TGF-β1 induces the expression of HDM2 in breast cancer driving its late metastatic stage102 suggests that, even in the absence of chromosomal duplication, the great levels of TGF-β expressed in the microenvironment (see following section) may drive high levels of HDM2 in MF.